EU to discuss easing Omicron travel curbs on Southern Africa

07 December 2021 - 08:16 By Lyubov Pronina
subscribe Just R20 for the first month. Support independent journalism by subscribing to our digital news package.
Subscribe now
European nations last month suspended most air travel from South Africa and six other countries in the region to stem the spread of the new variant while scientists try to assess its severity.
European nations last month suspended most air travel from South Africa and six other countries in the region to stem the spread of the new variant while scientists try to assess its severity.
Image: Bloomberg

European Union health ministers are expected to discuss Tuesday whether it’s advisable to adjust the travel curbs the bloc’s nations have imposed on Southern Africa in response to the omicron variant, an EU diplomat said.

One option under consideration is to require a PCR test for vaccinated third-country nationals from that region, which could allow a decision in a week or so to ease or lift some travel bans, according to an EU diplomat familiar with discussions ahead of Tuesday’s meeting in Brussels. 

The travel restrictions aren’t on the formal agenda for the meeting, and an EU official says that health ministers have no formal role in setting travel restrictions. The official said the meeting agenda includes booster doses, vaccination for children and measures states have put in place to combat the variant. 

European nations last month suspended most air travel from SA and six other countries in the region to stem the spread of the new variant while scientists try to assess its severity. Governments across the world tightened entry rules and some reintroduced quarantine measures, as airlines slashed thousands of flights.

The European Union co-ordinates travel guidelines within and into the bloc, but member nations are responsible for devising and implementing specific travel restrictions.

The European Commission will brief health ministers on the pharmaceutical strategy for Europe, which was proposed last year in an effort to ensure quality and safety of medicines, while boosting the sector’s global competitiveness.

 

  • More stories like this are available on bloomberg.com
  • ©2021 Bloomberg L.P.


subscribe Just R20 for the first month. Support independent journalism by subscribing to our digital news package.
Subscribe now